Repaglinide Tablet
Product Images NDC 72162-2558

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 72162-2558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622558)

This is a description of a medication containing Repaglinide. Each tablet contains 1 mg of Repaglinide USP. The usual dosage information can be found by scanning the package insert QR code. The tablets should be stored at 20° to 25°C (68° to 77°F) and protected from moisture by keeping the bottles tightly closed. It is important to keep this medication out of reach of children. The prescription should be dispensed in a container with a child-resistant closure. The medication is manufactured by Aurobindo Pharma Limited and relabeled by Bryant Ranch Prepack, Inc.*

FDA Label Image

Figure 1: Repaglinide In Combination With Pioglitazone: Hba1c Values (Repaglinide Fig1)

FDA Label Image

Chemical Structure (Repaglinide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.